L Brinch

Activated prothrombin complex concentrate (FEIBA^®) treatment during surgery in patients with inhibitors to FVIII/IX

Geir E. Tjønnfjord, L Brinch, Tobias Gedde‐Dahl et al. · Haemophilia · 2004 · 67 citations

Thrombosis, Antifibrotic Therapy, Surgical Procedures +14

Extramedullary plasmacytomas and solitary plasma cell tumours of bone

L Brinch, Einar Hannisdal, Arne Foss Abrahamsen et al. · European Journal Of Haematology · 1990 · 62 citations · Full text

Hematological Malignancy, Extramedullary Plasmacytomas, Solitary Extramedullary Plasmacytoma +14

Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium

W Wiktor-Jędrzejczak, Claire Dearden, Liesbeth C. de Wreede et al. · Leukemia · 2011 · 57 citations

Cell Therapy, Transplantation, Marrow Transplantation +8

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

Astrid Gruber, Magnus Björkholm, L Brinch et al. · Leukemia Research · 2003 · 35 citations

Hematological Malignancy, Psc 833, Phase I/ii Study +10

Decreased lung function in one year survivors of allogeneic bone marrow transplantation conditioned with high-dose busulphan and cyclophosphamide

MB Lund, Johny Kongerud, L Brinch et al. · European Respiratory Journal · 1995 · 31 citations · Full text

Transplantation, Marrow Transplantation, Heartlung Transplant +12